Concepedia
Statistics
Publications
13
Citations
973
H-Index
Active since
1988
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Institute for Medical Research
Bristol-Myers Squibb (Sweden)
Charles S. Parham is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and cardiology.
Publications per year
1988–2003
Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946
Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen et al. · Journal of Cardiovascular Pharmacology · 1995 · 258 citations
Medicine, Cardiology, Pharmacology +14
The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion
G. J. Grover, Steven Dzwonczyk, Charles S. Parham · Cardiovascular Research · 1993 · 151 citations
Medicine, Cardiology, Pharmacology +17
Cardioprotection with the KATP Opener Cromakalim Is Not Correlated with Ischemic Myocardial Action Potential Duration
Gary J. Grover, Albert J. DʼAlonzo, Charles S. Parham et al. · Journal of Cardiovascular Pharmacology · 1995 · 145 citations
The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs
Gary J. Grover, Steven Dzwonczyk, Charles S. Parham et al. · Cardiovascular Drugs and Therapy · 1990 · 134 citations
Medicine, Cardiology, Pharmacology +11
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide
G. J. Grover, A J D'Alonzo, Steven Dzwonczyk et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1996 · 69 citations
1–5 of 13